230 related articles for article (PubMed ID: 18178865)
1. MHC class II derived recombinant T cell receptor ligands protect DBA/1LacJ mice from collagen-induced arthritis.
Huan J; Kaler LJ; Mooney JL; Subramanian S; Hopke C; Vandenbark AA; Rosloniec EF; Burrows GG; Offner H
J Immunol; 2008 Jan; 180(2):1249-57. PubMed ID: 18178865
[TBL] [Abstract][Full Text] [Related]
2. Ethinyl estradiol treats collagen-induced arthritis in DBA/1LacJ mice by inhibiting the production of TNF-alpha and IL-1beta.
Subramanian S; Tovey M; Afentoulis M; Krogstad A; Vandenbark AA; Offner H
Clin Immunol; 2005 May; 115(2):162-72. PubMed ID: 15885639
[TBL] [Abstract][Full Text] [Related]
3. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a peptide analog of a determinant of type II collagen that suppresses collagen-induced arthritis.
Myers LK; Tang B; Rosloniec EF; Stuart JM; Chiang TM; Kang AH
J Immunol; 1998 Oct; 161(7):3589-95. PubMed ID: 9759881
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of invariant chain processing, antigen-induced proliferative responses, and the development of collagen-induced arthritis and experimental autoimmune encephalomyelitis by a small molecule cysteine protease inhibitor.
Podolin PL; Bolognese BJ; Carpenter DC; Davis TG; Johanson RA; Fox JH; Long E; Dong X; Marquis RW; Locastro SM; Terfloth GJ; Kurali E; Peterson JJ; Smith BR; McQueney MS; Yamashita DS; Capper-Spudich EA
J Immunol; 2008 Jun; 180(12):7989-8003. PubMed ID: 18523262
[TBL] [Abstract][Full Text] [Related]
6. Induction of tolerance against the arthritogenic antigen with type-II collagen peptide-linked soluble MHC class II molecules.
Park YK; Jung S; Park SH
BMB Rep; 2016 Jun; 49(6):331-6. PubMed ID: 26779996
[TBL] [Abstract][Full Text] [Related]
7. The natural soluble form of IL-18 receptor beta exacerbates collagen-induced arthritis via modulation of T-cell immune responses.
Veenbergen S; Smeets RL; Bennink MB; Arntz OJ; Joosten LA; van den Berg WB; van de Loo FA
Ann Rheum Dis; 2010 Jan; 69(1):276-83. PubMed ID: 19188194
[TBL] [Abstract][Full Text] [Related]
8. The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules.
Kjellén P; Brunsberg U; Broddefalk J; Hansen B; Vestberg M; Ivarsson I; Engström A; Svejgaard A; Kihlberg J; Fugger L; Holmdahl R
Eur J Immunol; 1998 Feb; 28(2):755-67. PubMed ID: 9521085
[TBL] [Abstract][Full Text] [Related]
9. Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis.
Ferrari-Lacraz S; Zanelli E; Neuberg M; Donskoy E; Kim YS; Zheng XX; Hancock WW; Maslinski W; Li XC; Strom TB; Moll T
J Immunol; 2004 Nov; 173(9):5818-26. PubMed ID: 15494535
[TBL] [Abstract][Full Text] [Related]
10. Collagen-induced arthritis in DBA/1 mice: cytokine gene activation following immunization with type II collagen.
Stasiuk LM; Abehsira-Amar O; Fournier C
Cell Immunol; 1996 Nov; 173(2):269-75. PubMed ID: 8912886
[TBL] [Abstract][Full Text] [Related]
11. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells specific for the same framework 3 region of the Vbeta8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis.
Kumar V; Aziz F; Sercarz E; Miller A
J Exp Med; 1997 May; 185(10):1725-33. PubMed ID: 9151697
[TBL] [Abstract][Full Text] [Related]
13. Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1/Th17 cells and expansion of regulatory T cells.
Zhao J; Li R; He J; Shi J; Long L; Li Z
Rheumatol Int; 2008 Nov; 29(1):9-16. PubMed ID: 18600328
[TBL] [Abstract][Full Text] [Related]
14. Treatment of IL-21R-Fc control autoimmune arthritis via suppression of STAT3 signal pathway mediated regulation of the Th17/Treg balance and plasma B cells.
Ryu JG; Lee J; Kim EK; Seo HB; Park JS; Lee SY; Moon YM; Yoo SH; Park YW; Park SH; Cho ML; Kim HY
Immunol Lett; 2015 Feb; 163(2):143-50. PubMed ID: 25447400
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein.
Banda NK; Vondracek A; Kraus D; Dinarello CA; Kim SH; Bendele A; Senaldi G; Arend WP
J Immunol; 2003 Feb; 170(4):2100-5. PubMed ID: 12574381
[TBL] [Abstract][Full Text] [Related]
16. Influence of polysaccharide fractions isolated from Caltha palustris L. on the cellular immune response in collagen-induced arthritis (CIA) in mice. A comparison with methotrexate.
Suszko A; Obmińska-Mrukowicz B
J Ethnopharmacol; 2013 Jan; 145(1):109-17. PubMed ID: 23123796
[TBL] [Abstract][Full Text] [Related]
17. Retinal attenuates inflammatory arthritis by reciprocal regulation of IL-17-producing T cells and Foxp3(+) regulatory T cells and the inhibition of osteoclastogenesis.
Park MK; Jhun JY; Lee SY; Oh HJ; Park MJ; Byun JK; Yoon BY; Park EM; Lee DG; Kwok SK; Park SH; Kim HY; Cho ML
Immunol Lett; 2012; 148(1):59-68. PubMed ID: 22841964
[TBL] [Abstract][Full Text] [Related]
18. I-Aq and I-Ap bind and present similar antigenic peptides despite differing in their ability to mediate susceptibility to autoimmune arthritis.
Brand DD; Whittington KB; Rosloniec EF
Autoimmunity; 2001; 34(2):133-45. PubMed ID: 11905843
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with an immunodominant peptide of bovine type II collagen induces an anti-TCR response, and modulates the onset and severity of collagen-induced arthritis.
Honda A; Ametani A; Matsumoto T; Iwaya A; Kano H; Hachimura S; Ohkawa K; Kaminogawa S; Suzuki K; Sercarz EE; Kumar V
Int Immunol; 2004 May; 16(5):737-45. PubMed ID: 15096482
[TBL] [Abstract][Full Text] [Related]
20. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
